AVLSA
FSTX

Atlas Venture Life Science Advisors’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Atlas Venture Life Science Advisors’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$3.79M Hold
2022
Q3 		$3.07M Hold
2022
Q2 		$3.75M Hold
2022
Q1 		$2.13M Hold
2021
Q4 		$3.01M Buy